DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes
Clinical trial NCT06875193 · RECRUITING
Trial details
- NCT number
- NCT06875193
- Sponsor
- Dong Wha Pharmaceutical Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-28
- Primary completion
- 2025-12-31
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.